Li-Cycle Holdings Analyst Ratings
Li-Cycle Holdings Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/16/2023 | 55.9% | Chardan Capital | $8 → $7 | Maintains | Buy |
08/15/2023 | 78.17% | Wedbush | → $8 | Reiterates | Outperform → Outperform |
08/01/2023 | 78.17% | Chardan Capital | → $8 | Reiterates | Buy → Buy |
06/26/2023 | 55.9% | Piper Sandler | $10 → $7 | Maintains | Overweight |
05/16/2023 | 78.17% | Chardan Capital | → $8 | Reiterates | Buy → Buy |
05/04/2023 | 89.31% | Cantor Fitzgerald | → $8.5 | Initiates Coverage On | → Buy |
05/03/2023 | 78.17% | Chardan Capital | $10 → $8 | Maintains | Buy |
03/31/2023 | 78.17% | TD Securities | $10 → $8 | Maintains | Outperform |
03/31/2023 | 78.17% | Baird | $7 → $8 | Maintains | Neutral |
02/28/2023 | 122.72% | Chardan Capital | → $10 | Reiterates | → Buy |
02/01/2023 | 55.9% | Citigroup | $7.5 → $7 | Maintains | Buy |
01/31/2023 | 122.72% | Chardan Capital | $13 → $10 | Maintains | Buy |
01/31/2023 | 55.9% | Baird | $8 → $7 | Maintains | Neutral |
01/25/2023 | -10.91% | Morgan Stanley | $7 → $4 | Downgrades | Equal-Weight → Underweight |
12/15/2022 | 67.04% | Citigroup | $8 → $7.5 | Maintains | Buy |
09/30/2022 | 55.9% | Morgan Stanley | $8 → $7 | Maintains | Equal-Weight |
09/15/2022 | 189.53% | Chardan Capital | $18 → $13 | Maintains | Buy |
09/15/2022 | 78.17% | Baird | $11 → $8 | Maintains | Neutral |
09/15/2022 | 122.72% | BMO Capital | $12 → $10 | Maintains | Outperform |
06/15/2022 | 122.72% | Cowen & Co. | $14 → $10 | Maintains | Outperform |
06/15/2022 | 144.99% | Baird | $9 → $11 | Maintains | Neutral |
06/03/2022 | 78.17% | Morgan Stanley | $10 → $8 | Maintains | Equal-Weight |
04/07/2022 | 122.72% | Citigroup | $11 → $10 | Maintains | Buy |
02/10/2022 | 122.72% | Morgan Stanley | → $10 | Downgrades | Overweight → Equal-Weight |
01/13/2022 | 300.89% | Chardan Capital | $17 → $18 | Maintains | Buy |
11/23/2021 | 278.62% | Chardan Capital | → $17 | Initiates Coverage On | → Buy |
09/22/2021 | 234.08% | UBS | → $15 | Initiates Coverage On | → Buy |
09/20/2021 | 211.8% | Wedbush | → $14 | Initiates Coverage On | → Outperform |
09/14/2021 | 234.08% | Morgan Stanley | → $15 | Initiates Coverage On | → Overweight |
09/10/2021 | 189.53% | BMO Capital | → $13 | Initiates Coverage On | → Outperform |
08/23/2021 | 144.99% | Baird | → $11 | Initiates Coverage On | → Neutral |
08/23/2021 | 234.08% | Cowen & Co. | → $15 | Initiates Coverage On | → Outperform |
日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
---|---|---|---|---|---|
08/16/2023 | 55.9% | 查尔丹资本 | $8→$7 | 维护 | 买 |
2023年08月15日 | 78.17% | 韦德布什 | →$8 | 重申 | 跑赢→跑赢大盘 |
08/01/2023 | 78.17% | 查尔丹资本 | →$8 | 重申 | 购买→购买 |
2023/06/26 | 55.9% | 派珀·桑德勒 | $10→$7 | 维护 | 超重 |
2023年05月16日 | 78.17% | 查尔丹资本 | →$8 | 重申 | 购买→购买 |
05/04/2023 | 89.31% | 康托·菲茨杰拉德 | →$8.5 | 开始承保 | →购买 |
05/03/2023 | 78.17% | 查尔丹资本 | $10→$8 | 维护 | 买 |
03/31/2023 | 78.17% | 道明证券 | $10→$8 | 维护 | 跑赢大盘 |
03/31/2023 | 78.17% | 贝尔德 | $7→$8 | 维护 | 中性 |
02/28/2023 | 122.72% | 查尔丹资本 | →$10 | 重申 | →购买 |
02/01/2023 | 55.9% | 花旗集团 | $7.5→$7 | 维护 | 买 |
2023年1月31日 | 122.72% | 查尔丹资本 | $13→$10 | 维护 | 买 |
2023年1月31日 | 55.9% | 贝尔德 | $8→$7 | 维护 | 中性 |
2023年1月25日 | -10.91% | 摩根士丹利 | $7→$4 | 评级下调 | 等重→减码 |
2022年12月15日 | 67.04% | 花旗集团 | $8→$7.5 | 维护 | 买 |
09/30/2022 | 55.9% | 摩根士丹利 | $8→$7 | 维护 | 等重 |
09/15/2022 | 189.53% | 查尔丹资本 | $18→$13 | 维护 | 买 |
09/15/2022 | 78.17% | 贝尔德 | $11→$8 | 维护 | 中性 |
09/15/2022 | 122.72% | 蒙特利尔银行资本 | $12→$10 | 维护 | 跑赢大盘 |
2022/06/15 | 122.72% | 考恩公司 | $14→$10 | 维护 | 跑赢大盘 |
2022/06/15 | 144.99% | 贝尔德 | $9→$11 | 维护 | 中性 |
06/03/2022 | 78.17% | 摩根士丹利 | $10→$8 | 维护 | 等重 |
04/07/2022 | 122.72% | 花旗集团 | $11→$10 | 维护 | 买 |
02/10/2022 | 122.72% | 摩根士丹利 | →$10 | 评级下调 | 超重→等重 |
2022年01月13日 | 300.89% | 查尔丹资本 | $17→$18 | 维护 | 买 |
2021年11月23日 | 278.62% | 查尔丹资本 | →$17 | 开始承保 | →购买 |
09/22/2021 | 234.08% | 瑞银集团 | →$15 | 开始承保 | →购买 |
09/20/2021 | 211.8% | 韦德布什 | →$14 | 开始承保 | →跑赢大盘 |
09/14/2021 | 234.08% | 摩根士丹利 | →$15 | 开始承保 | →超重 |
09/10/2021 | 189.53% | 蒙特利尔银行资本 | →$13 | 开始承保 | →跑赢大盘 |
2021/08/23 | 144.99% | 贝尔德 | →$11 | 开始承保 | →中性 |
2021/08/23 | 234.08% | 考恩公司 | →$15 | 开始承保 | →跑赢大盘 |
What is the target price for Li-Cycle Holdings (LICY)?
Li周期控股(利好)的目标价是多少?
The latest price target for Li-Cycle Holdings (NYSE: LICY) was reported by Chardan Capital on August 16, 2023. The analyst firm set a price target for $7.00 expecting LICY to rise to within 12 months (a possible 55.90% upside). 19 analyst firms have reported ratings in the last year.
查丹资本于2023年8月16日报道了Li周期控股(纽约证券交易所代码:LICE)的最新目标价。这家分析公司将目标价定为7.00美元,预计里奇将在12个月内上涨至55.90%(可能上涨55.90%)。去年有19家分析公司公布了评级。
What is the most recent analyst rating for Li-Cycle Holdings (LICY)?
分析师对Li周期控股(LICY)的最新评级是多少?
The latest analyst rating for Li-Cycle Holdings (NYSE: LICY) was provided by Chardan Capital, and Li-Cycle Holdings maintained their buy rating.
对Li周期控股(纽约证券交易所代码:LICE)的最新分析师评级由查尔丹资本提供,Li周期控股维持买入评级。
When is the next analyst rating going to be posted or updated for Li-Cycle Holdings (LICY)?
Li周期控股(LICY)的下一次分析师评级将于何时发布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Li-Cycle Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Li-Cycle Holdings was filed on August 16, 2023 so you should expect the next rating to be made available sometime around August 16, 2024.
分析师在进行了广泛的研究后得出了股票评级,这些研究包括查阅公开的财务报表,与Li周期控股的高管和客户交谈,以及收听收益电话会议。大多数分析师每三个月就会这样做一次,所以你每年应该会得到每家公司每家公司的4个评级。Li周期控股的上一次评级是在2023年8月16日提交的,因此你应该预计下一次评级将在2024年8月16日左右公布。
Is the Analyst Rating Li-Cycle Holdings (LICY) correct?
分析师对Li周期控股(LICY)的评级正确吗?
While ratings are subjective and will change, the latest Li-Cycle Holdings (LICY) rating was a maintained with a price target of $8.00 to $7.00. The current price Li-Cycle Holdings (LICY) is trading at is $4.49, which is out of the analyst's predicted range.
虽然评级是主观的,并将发生变化,但最新的Li周期控股(LICY)评级维持不变,目标价在8.00美元至7.00美元之间。Li周期控股目前的股价为4.49美元,超出了分析师的预测区间。